Management of Exercise-Induced Cough in a 7-Year-Old with Asthma
This child has exercise-induced bronchoconstriction (EIB) and should receive a short-acting beta-2 agonist (salbutamol/albuterol) 15-30 minutes before physical activity, delivered via metered-dose inhaler with a spacer device.
Immediate Management Strategy
Pre-Exercise Treatment
- Administer salbutamol 15-30 minutes before exercise 1
- Use a metered-dose inhaler (MDI) with a large volume spacer device—this is essential for proper lung deposition in children 2
- Most 7-year-olds cannot coordinate an unmodified MDI properly 2
- This provides bronchoprotection for approximately 4 hours 3
Non-Pharmacologic Approach
Implement a warm-up routine before vigorous activity 4:
- 10-15 minutes of interval or combination warm-up exercise
- This induces a "refractory period" lasting up to 2 hours
- Variable high-intensity intervals are more effective than continuous low or high-intensity warm-up
- This recommendation is strong because it reduces symptoms and prevents injury 4
Assessment of Underlying Asthma Control
Critical decision point: If this child requires salbutamol more than once daily or has symptoms beyond just exercise, the asthma is inadequately controlled and requires controller therapy 5, 6.
Goals of Successful Management 2:
- Minimal daytime symptoms
- No nighttime awakening
- No missed school days
- Full participation in sports and activities
- Infrequent need for relief medications
When to Escalate Treatment
Add daily inhaled corticosteroid (ICS) if 5, 6:
- Salbutamol needed more than twice weekly
- Symptoms occur with daily activities (not just scheduled exercise)
- Nighttime cough or wheeze present
- Activity limitation beyond the 15-minute exercise trigger
Use the lowest effective ICS dose (typically starting <400 µg/day to minimize growth effects) 2
Alternative Controller Options
If ICS alone doesn't provide adequate control 5:
- Leukotriene receptor antagonists (LTRAs): Can be added to ICS or used alone; provide persistent protection without tolerance development 5, 3
- Advantage: Oral administration, no tolerance with regular use
- Particularly useful if the child has allergic rhinitis
Avoid long-acting beta-agonists (LABAs) as monotherapy in children with normal baseline lung function, as regular use causes tolerance and diminishes bronchoprotection 7, 5
Important Caveats
Tolerance Development
- Daily salbutamol use leads to tolerance—effectiveness decreases with frequent administration 1, 6
- If pre-exercise salbutamol is needed daily, this signals inadequate asthma control requiring controller therapy
- LTRAs do not cause tolerance, making them preferable for children needing daily protection 5, 3
Proper Inhaler Technique
Before escalating therapy, verify 2:
- Age-appropriate inhaler device being used
- Correct technique with spacer
- Parents understand "reliever" vs. "preventer" medications
Environmental Triggers
Address modifiable factors 2:
- Maternal/household smoking (most important)
- Cold, dry air exposure
- Consider face masks in cold weather to humidify inspired air 7
Follow-Up Monitoring
Track these outcomes at each visit 2:
- Days missed from school
- Frequency of daytime and nighttime cough
- Activity limitation and wheeze
- Frequency of relief medication use
- Height and weight velocity (if on ICS)
Safety Profile
Salbutamol in approved dosages is safe for preventing EIB in children when used appropriately (less than daily) 1, 5. The key is recognizing when frequent use indicates the need for anti-inflammatory controller therapy rather than continued reliance on bronchodilators alone.